ebaresdax   Click here for help

GtoPdb Ligand ID: 12149

Synonyms: ACP-044 | ACP044 | compound 1 [WO2020159643A1] [1]
Compound class: Synthetic organic
Comment: The chemical structure for ebaresdax is claimed in Cersci Therapeutics' patent WO2020159643A1 [1], which allowed us to associate this structure with their clinical lead candidate ACP-044. This was confirmed by synonym matches on PubChem. Ebaresdax (ACP-044) is a first-in-class, orally administered, non-opioid analgesic that was developed for potential to treat neuropathic, surgical and osteoarthritic pain.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 107.22
Molecular weight 266.07
XLogP 1.95
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)[C@H]1N=C(SC1(C)C)Nc1ccccc1O
Isomeric SMILES CC1([C@H](N=C(S1)Nc1ccccc1O)C(=O)O)C
InChI InChI=1S/C12H14N2O3S/c1-12(2)9(10(16)17)14-11(18-12)13-7-5-3-4-6-8(7)15/h3-6,9,15H,1-2H3,(H,13,14)(H,16,17)/t9-/m1/s1
InChI Key OASISJWJIHWVKX-SECBINFHSA-N
References
1. Dax S. (2020)
Methods of treating pain with a thiazoline anti-hyperalgesic.
Patent number: WO2020159643A1. Assignee: Cersci Therapeutics, Inc.. Priority date: 01/02/2019. Publication date: 06/08/2020.